JPMorgan Chase & Co’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-20,875
| Closed | -$26.5K | – | 6916 |
|
|
2023
Q3 | $26.5K | Buy |
20,875
+11,403
| +120% | +$14.5K | ﹤0.01% | 5078 |
|
|
2023
Q2 | $3.09K | Buy |
9,472
+5,733
| +153% | +$1.87K | ﹤0.01% | 5370 |
|
|
2023
Q1 | $2K | Buy |
3,739
+3,227
| +630% | +$1.73K | ﹤0.01% | 5591 |
|
|
2022
Q4 | $0 | Buy |
512
+451
| +739% | – | ﹤0.01% | 6107 |
|
|
2022
Q3 | $0 | Hold |
61
| – | – | ﹤0.01% | 5964 |
|
|
2022
Q2 | $0 | Hold |
61
| – | – | ﹤0.01% | 6045 |
|
|
2022
Q1 | $0 | Hold |
61
| – | – | ﹤0.01% | 6065 |
|
|
2021
Q4 | $0 | Hold |
61
| – | – | ﹤0.01% | 6017 |
|
|
2021
Q3 | $0 | Sell |
61
-211,944
| -100% | – | ﹤0.01% | 5847 |
|
|
2021
Q2 | $1.12M | Buy |
212,005
+36,573
| +21% | +$193K | ﹤0.01% | 3566 |
|
|
2021
Q1 | $815K | Sell |
175,432
-53,569
| -23% | -$249K | ﹤0.01% | 3780 |
|
|
2020
Q4 | $755K | Buy |
229,001
+16,919
| +8% | +$55.8K | ﹤0.01% | 3525 |
|
|
2020
Q3 | $701K | Sell |
212,082
-69,620
| -25% | -$230K | ﹤0.01% | 3245 |
|
|
2020
Q2 | $950K | Sell |
281,702
-3,543
| -1% | -$11.9K | ﹤0.01% | 3037 |
|
|
2020
Q1 | $1.09M | Sell |
285,245
-47,239
| -14% | -$181K | ﹤0.01% | 2901 |
|
|
2019
Q4 | $2.01M | Sell |
332,484
-37,355
| -10% | -$226K | ﹤0.01% | 2698 |
|
|
2019
Q3 | $2.8M | Buy |
369,839
+223,072
| +152% | +$1.69M | ﹤0.01% | 2557 |
|
|
2019
Q2 | $1.87M | Buy |
+146,767
| New | +$1.87M | ﹤0.01% | 2708 |
|
|
2019
Q1 | – | Sell |
-143,608
| Closed | -$427K | – | 5026 |
|
|
2018
Q4 | $427K | Buy |
+143,608
| New | +$427K | ﹤0.01% | 3460 |
|
|
2018
Q2 | – | Sell |
-12,217
| Closed | -$106K | – | 4880 |
|
|
2018
Q1 | $106K | Buy |
12,217
+9,701
| +386% | +$84.2K | ﹤0.01% | 3915 |
|
|
2017
Q4 | $32K | Buy |
2,516
+2,016
| +403% | +$25.6K | ﹤0.01% | 4278 |
|
|
2017
Q3 | $5K | Sell |
500
-325,950
| -100% | -$3.26M | ﹤0.01% | 4131 |
|
|
2017
Q2 | $5.54M | Buy |
326,450
+325,950
| +65,190% | +$5.53M | ﹤0.01% | 2076 |
|
|
2017
Q1 | $10K | Buy |
+500
| New | +$10K | ﹤0.01% | 4212 |
|
|
2016
Q2 | – | Sell |
-174,900
| Closed | -$1.65M | – | 4392 |
|
|
2016
Q1 | $1.65M | Sell |
174,900
-5,100
| -3% | -$48.2K | ﹤0.01% | 2451 |
|
|
2015
Q4 | $1.81M | Buy |
+180,000
| New | +$1.81M | ﹤0.01% | 2415 |
|